Apyx Medical Corp

BOV

Company Profile

  • Business description

    Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.

  • Contact

    5115 Ulmerton Road
    ClearwaterFL33760
    USA

    T: +1 727 384-2323

    E: [email protected]

    https://apyxmedical.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    205

Stocks News & Analysis

stocks

ASX tech share upgraded following AI contract wins

Strong demand for AI infrastructure drives fair value lift.
stocks

5 star fully franked ASX dividend payer

Investors in cheap ASX share with a narrow moat enjoys a high yield, but there are risks investors should be aware of.
stocks

An undervalued stock to buy that even Warren Buffett likes

Trading at an 18% discount, this wide-moat stock is a rare find.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,969.2082.600.93%
CAC 407,992.9142.96-0.53%
DAX 4025,340.0359.18-0.23%
Dow JONES (US)51,349.92131.59-0.26%
FTSE 10010,643.847.130.07%
HKSE24,613.2789.700.37%
NASDAQ26,797.5422.84-0.09%
Nikkei 22566,753.721,272.451.94%
NZX 50 Index13,834.39150.761.10%
S&P 5007,670.8412.85-0.17%
S&P/ASX 2008,789.3080.000.92%
SSE Composite Index3,842.1911.740.31%

Market Movers